Lehmann S, Uhlemann M, Leontyev S, Meyer A, Garbade J, Seeburger J, Laflamme M, Bittner H B, Mohr F W
Division of Cardiovascular Surgery, Heart Center Leipzig of the University of Leipzig, Leipzig, Germany
Division of Cardiology, Heart Center Leipzig of the University of Leipzig, Leipzig, Germany.
Perfusion. 2015 Mar;30(2):154-60. doi: 10.1177/0267659114540975. Epub 2014 Jul 2.
Mechanical lung assist (MLA; extracorporeal membrane oxygenation (ECMO) or extracorporeal lung assist (ECLA)) is increasingly used as a temporary bridge to lung transplantation (LTx). This study was designed to evaluate the impact of preoperative MLA on the operative outcome, including longer-term survival, in comparison to patients undergoing LTx without preoperative MLA.
A total of 143 patients underwent LTx at our institution from 2002 to 2011. Forty-three percent (n=62) of patients presented with idiopathic pulmonary fibrosis and 71% (n=102) presented with severely elevated pulmonary artery pressure.
Thirteen patients (9.1%) required pre-LTx MLA support (age 44 ±13 years, double LTx 73.3%, female gender 53%) whereas 130 patients did not (age 52 ±11 years, double LTx 41.5%, female gender 36.9%). In one patient, MLA was successfully weaned and the patient underwent subsequent LTx. All patients in the MLA group were intraoperatively supported with continuous ECMO. One patient had to be supported with MLA after LTx for a period of 8 days. The short-term and mid-term postoperative survival of the MLA patient group was not significantly different from the non-MLA group (LogRank p=0.28). The 30-day, 90-day and 1-year survivals were 95%, 90% and 71%, respectively, in the patients without MLA compared to 85%, 77% and 68% in the MLA group.
MLA has no impact on long-term survival rate in LTx patients, but has an influence in postoperative survival. MLA support is a valuable tool to bridge unstable patients to LTx.
机械肺辅助(MLA;体外膜肺氧合(ECMO)或体外肺辅助(ECLA))越来越多地被用作肺移植(LTx)的临时桥梁。本研究旨在评估术前MLA与未接受术前MLA的LTx患者相比,对手术结果(包括长期生存率)的影响。
2002年至2011年期间,共有143例患者在我院接受了LTx。43%(n = 62)的患者患有特发性肺纤维化,71%(n = 102)的患者肺动脉压力严重升高。
13例患者(9.1%)在LTx前需要MLA支持(年龄44±13岁,双侧LTx占73.3%,女性占53%),而130例患者不需要(年龄52±11岁,双侧LTx占41.5%,女性占36.9%)。1例患者成功撤机,随后接受了LTx。MLA组的所有患者在术中均接受了持续ECMO支持。1例患者在LTx后需要MLA支持8天。MLA患者组的术后短期和中期生存率与非MLA组无显著差异(LogRank p = 0.28)。未接受MLA的患者30天、90天和1年生存率分别为95%、90%和71%,而MLA组分别为85%、77%和68%。
MLA对LTx患者的长期生存率没有影响,但对术后生存率有影响。MLA支持是将不稳定患者过渡到LTx的宝贵工具。